# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Lauren Lieberman maintains Clorox (NYSE:CLX) with a Underweight and lowers the price target from $136 to $132.
Citigroup analyst Wendy Nicholson maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $155 to $150.
UBS analyst Peter Grom maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $164 to $159.
JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $159 to $158.
Evercore ISI Group analyst Javier Escalante maintains Clorox (NYSE:CLX) with a Underperform and lowers the price target from...
Clorox (NYSE:CLX) reported quarterly earnings of $1.71 per share which beat the analyst consensus estimate of $1.37 by 24.82 pe...
Investor apprehension grips Wall Street with major indices showing midday losses on Tuesday in New York trading, ahead of the F...
U.S. stocks appear to be on the back foot early on Tuesday, with index futures trading modestly lower in early pre-market activ...